Somryst
Somryst (651010) is a mental health/function therapeutic software (FDA Class II; FDA product code QVO, Computerized Behavioral Therapy Device For Insomnia) made by Nox Medical Ehf, cleared under FDA 510(k) K191716 on 23 Mar 2020 and listed in FDA GUDID since 30 Dec 2024 (UDI-DI 15694311112112), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number15694311112112 | Date30 Dec 2024 | StatusListed |
| United States | FDA 510(k)SESE | NumberK191716 | Date23 Mar 2020 | StatusActive |
Official records
- AccessGUDID record 15694311112112
- FDA 510(k) database K191716
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K191716 decided 23 Mar 2020 Active
- FDA GUDID UDI-DI 15694311112112 listed 30 Dec 2024 Listed
Timeline
- Cleared FDA 510(k) K191716
- Listed FDA GUDID 15694311112112
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / Ref / Catalog
- SOMRYST, 651010
- Primary DI / UDI-DI
- 15694311112112
- 510(k) Number
- FDA product code
- QVO
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution